Catalyst Wire Dossier Catalyst Wire Dossier

napabucasin

napabucasin
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for napabucasin, covering 2021-06-10 to 2022-04-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer [Phase 3]

See pricing